The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer

It has been well established that mutations in the tumor suppressor gene, p53, occur readily in a vast majority of cancer tumors, including ovarian cancer. Typically diagnosed in stages three or four, ovarian cancer is the fifth leading cause of death in women, despite accounting for only 2.5% of al...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallis, Bryce, Bowman, Katherine Redd, Lu, Phong, Lim, Carol S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855757/
https://www.ncbi.nlm.nih.gov/pubmed/36671544
http://dx.doi.org/10.3390/biom13010159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855757/
https://www.ncbi.nlm.nih.gov/pubmed/36671544
http://dx.doi.org/10.3390/biom13010159

Ejemplares similares